Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Canadian Law Professor Urges Country to Cancel Ebola Vaccine License with NewLink, Transfer Rights to Bigger Company

October 20, 2014 1:57 pm | by Helen Branswell, The Canadian Press | News | Comments

A prominent law professor is urging the federal government to terminate an American company's licence for a Canadian-made Ebola vaccine. The company, NewLink Genetics, doesn't have the capacity to develop the much-needed vaccine, argues Amir Attaran, a professor of law and population health at the University of Ottawa.

TOPICS:

Cubist Pharma CEO Bonney to Retire

October 20, 2014 1:35 pm | News | Comments

Antibiotic maker Cubist Pharmaceuticals said that Michael Bonney will retire as CEO at the end of the year, and the company said it will promote President Robert Perez to take his place.           

TOPICS:

Valeant Considering Higher Bid for Allergan after Reporting Strong Q3 Results

October 20, 2014 1:26 pm | by Ross Marowits, The Canadian Press | News | Comments

Valeant Pharmaceuticals said that its strong third-quarter results and a higher growth forecast give it ammunition to win over reluctant takeover target Botox maker Allergan with an increased bid at the appropriate time.     

TOPICS:
Advertisement

Pharmaceutical Processing's October 2014 Issue

October 20, 2014 11:34 am | Digital Editions | Comments

The October issue of Pharmaceutical Processing describes Capsugel’s merger with Bend Research and Encap to create a comprehensive solid dosage form solutions group. The issue also features articles on supply chain trends including how to reduce risk, managing a clinical supply chain,  a look at the best printing and coding solutions, and the move to the fully connected enterprise. Other articles focus on particle size analysis, disposable chromatography technologies, and monitoring potency assays.

TOPICS:

BioProcess Technology Consultants Acquires CTD Quality Consulting

October 20, 2014 9:37 am | News | Comments

CTD Quality Consulting, founded in 2004, specializes in regulatory submissions, regulatory strategy, GxP compliance training, and inspection readiness for pharmaceutical, biopharmaceutical, and medical device companies      

TOPICS:

Halozyme Receives FDA Approval for Additional Manufacturing Facilities For Hylenex Recombinant

October 20, 2014 9:02 am | News | Comments

The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the Patheon facility in Greenville, North Carolina, for production of finished Hylenex product.

TOPICS:

Opinion: The Failed AbbVie Deal Slammed Markets

October 20, 2014 8:57 am | Videos | Comments

Business World Columnist Holman Jenkins Jr. on what’s behind AbbVie’s decision not to merge with Dublin-based Shire.                       

TOPICS:

Study: Thousands of Children Get Incorrect Medication

October 20, 2014 8:46 am | Videos | Comments

Researchers in Ohio say that tens of thousands of children are given the wrong medication or dosing every year. Also, doctors say that women are more likely to develop anxiety and depression after a heart attack.       

TOPICS:
Advertisement

Growing Pharmaceutical Industry Embraces Innovation

October 20, 2014 8:37 am | by Julie Ackerman, Senior Director, PR and Communications, PMMI | Blogs | Comments

The global pharmaceutical industry will reach nearly $1.2 trillion in sales by 2017, representing a growth rate of up to 6 percent per year, according to The IMS Institute for Healthcare Informatics. To remain competitive in this growing market, pharmaceutical manufacturers are continually looking to evolve their operations to keep up with today’s trends, create greater efficiencies and comply with the newest regulations.

TOPICS:

Ebola Lapses Persisted for Days at Dallas Hospital

October 20, 2014 8:31 am | by MATT SEDENSKY, Associated Press | News | Comments

Just minutes after Thomas Eric Duncan arrived for a second time at the emergency room, the word is on his chart: "Ebola." But despite all the warnings that the deadly virus could arrive unannounced at an American hospital, for days after the admission, his caregivers are vulnerable.

TOPICS:

China Gives $6M for Food in Ebola Countries

October 20, 2014 8:24 am | News | Comments

China has donated $6 million to help stave off food shortages in the three African countries worst affected by the Ebola virus, the World Food Program announced Monday, part of Beijing's growing assistance to a continent where its companies have become major investors.

TOPICS:

WHO: Nigeria's Ebola Outbreak is Officially Over

October 20, 2014 8:19 am | by BASHIR ADIGUN, Associated Press; MARIA CHENG, Associated Press | News | Comments

The World Health Organization declared on Monday that Nigeria is free of Ebola, a rare victory in the months-long battle against the fatal disease.                 

TOPICS:

Clinics Recommend Hospitals for Ebola Testing

October 20, 2014 8:14 am | by JULIE WATSON, Associated Press | News | Comments

When a Dallas County sheriff's deputy who had entered the apartment of the first patient to die from Ebola in the U.S. started feeling ill himself, he didn't rush to the nearest hospital. He chose an urgent care clinic.     

TOPICS:

Anti-Abuse Label Approved for Painkiller Embeda

October 17, 2014 8:36 pm | by The Associated Press | News | Comments

The U.S. Food and Drug Administration says it has approved new labeling for another opioid designed to limit painkiller abuse. The FDA said Friday that Pfizer Inc.'s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted.

TOPICS:

Obama Names Ebola 'Czar' as Precautions Expand

October 17, 2014 11:49 am | by JIM KUHNHENN, Associated Press | News | Comments

President Barack Obama on Friday turned to a trusted adviser to lead the nation's Ebola response as efforts to clamp down on any possible route of infection from three Texas cases expanded, reaching a cruise ship at sea and multiple airline flights.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading